Price-file publication check · 45 CFR § 180
F · 55
This hospital's published file contains little of what § 180 requires.
●Machine-readable file published: assessment threshold met
○Gross / standard charges: below assessment threshold
○Discounted cash price: below assessment threshold
●Payer-specific negotiated rates: assessment threshold met
○Min / max negotiated charges: below assessment threshold
●Free, public, no login required: assessment threshold met
Procedures listed
19,188
Insurances with rates
6
CPT / HCPCS codes
17,873
Most expensive procedures (gross)
J9043
$154,982
CABAZITAXEL 60 MG/6ML IV SOLN
Gross
$154,982
J0223
$119,002
GIVOSIRAN SODIUM 189 MG/ML SC SOLN
Gross
$119,002
J9347
$114,454
TREMELIMUMAB-ACTL 300 MG/15ML IV SOLN
Gross
$114,454
J3357
$80,569
USTEKINUMAB 90 MG/ML SC SOSY
Gross
$80,569
J0638
$61,880
CANAKINUMAB 150 MG/ML SC SOLN
Gross
$61,880
J2350
$57,156
OCRELIZUMAB 300 MG/10ML IV SOLN
Gross
$57,156
J3245
$49,169
TILDRAKIZUMAB-ASMN 100 MG/ML SC SOSY
Gross
$49,169
J9298
$42,234
NIVOLUMAB-RELATLIMAB-RMBW 240-80 MG/20ML IV SOLN
Gross
$42,234
J9345
$40,375
RETIFANLIMAB-DLWR 500 MG/20ML IV SOLN
Gross
$40,375
J9306
$36,265
PERTUZUMAB 420 MG/14ML IV SOLN
Gross
$36,265
J9042
$36,019
BRENTUXIMAB VEDOTIN 50 MG IV SOLR
Gross
$36,019
J9277
$32,948
PEMBROLIZUMAB-BERAHYALUR-PMPH 395-4800 MG -UNT/2.4ML SC SOLN
Gross
$32,948
J9272
$32,945
DOSTARLIMAB-GXLY 500 MG/10ML IV SOLN
Gross
$32,945
J9022
$32,363
ATEZOLIZUMAB 1200 MG/20ML IV SOLN
Gross
$32,363
J9119
$32,006
CEMIPLIMAB-RWLC 350 MG/7ML IV SOLN
Gross
$32,006
J9144
$30,586
DARATUMUMAB-HYALURONIDASE-FIHJ 1800-30000 MG-UT/15ML SC SOLN
Gross
$30,586
J2327
$29,402
RISANKIZUMAB-RZAA 600 MG/10ML IV SOLN
Gross
$29,402
J3380
$26,608
VEDOLIZUMAB 300 MG IV SOLR
Gross
$26,608
J9316
$25,519
PERTUZ-TRASTUZ-HYALURON-ZZXF 60-60-2000 MG-MG-U/ML SC SOLN
Gross
$25,519
J9301
$24,875
OBINUTUZUMAB 1000 MG/40ML IV SOLN
Gross
$24,875
J9228
$24,797
IPILIMUMAB 5 MG/ML IV SOLN (COMBINED)
Gross
$24,797
J1930
$23,407
LANREOTIDE ACETATE 120 MG/0.5ML SC SOLN
Gross
$23,407
J2323
$23,372
NATALIZUMAB 300 MG/15ML IV CONC
Gross
$23,372
J3101
$23,163
TENECTEPLASE 25 MG IV KIT
Gross
$23,163
J9223
$22,584
LURBINECTEDIN 4 MG IV SOLR
Gross
$22,584
J0180
$21,222
AGALSIDASE BETA 35 MG IV SOLR
Gross
$21,222
J1459
$20,807
PRIVIGEN 40 GM/400ML IV SOLN
Gross
$20,807
J9308
$20,349
RAMUCIRUMAB 10 MG/ML IV SOLN (COMBINED)
Gross
$20,349
24341
$19,460
HC REPAIR TENDON/MUSCLE UPPER ARM/ELBOW EA TDN/MUSC
Gross
$19,460
J9063
$18,302
MIRVETUXIMAB SORAVTANSINE-GYNX 100 MG/20ML IV SOLN
Gross
$18,302
J1299
$17,170
ECULIZUMAB 300 MG/30ML IV SOLN
Gross
$17,170
J9271
$16,474
PEMBROLIZUMAB 100 MG/4ML IV SOLN
Gross
$16,474
0313U
$16,472
B* HC ONC PANCREATIC FLUID NGS ANALYS DNA&MRNA SEQ 74
Gross
$16,472
21330
$15,876
HC OPEN TX NASAL FX COMP W/INT&/XTRNL SKELETAL FI
Gross
$15,876
21431
$15,876
HC CLOSED TX CRANIOFACIAL SEPARATION
Gross
$15,876
J0517
$15,852
BENRALIZUMAB 30 MG/ML SC SOSY
Gross
$15,852
Q5152
$15,453
ECULIZUMAB-AEEB 300 MG/30ML IV SOLN
Gross
$15,453
J1569
$14,271
GAMMAGARD 30 GM/300ML IJ SOLN
Gross
$14,271
J2506
$12,995
PEGFILGRASTIM 6 MG/0.6ML SC SOSY
Gross
$12,995
J2356
$12,644
TEZEPELUMAB-EKKO 210 MG/1.91ML SC (COMBINED)
Gross
$12,644
J2353
$12,637
OCTREOTIDE ACETATE 20 MG IM KIT
Gross
$12,637
J9312
$12,365
RITUXIMAB 10 MG/ML IV CONC (COMBINED)
Gross
$12,365
C1767
$12,150
DEVICE NEUROSTIMULATOR F15
Gross
$12,150
Q5151
$12,019
ECULIZUMAB-AAGH 300 MG/30ML IV SOLN
Gross
$12,019
81412
$11,979
B* HC ASHKENAZI JEWISH ASSOC DSRDRS GEN SEQ ANAL 9 GEN
Gross
$11,979
J9173
$11,935
DURVALUMAB 500 MG/10ML IV SOLN
Gross
$11,935
J9309
$11,461
POLATUZUMAB VEDOTIN-PIIQ 30 MG IV SOLR
Gross
$11,461
J0739
$11,410
CABOTEGRAVIR ER 600 MG/3ML IM SUER
Gross
$11,410
J0896
$11,264
LUSPATERCEPT-AAMT 25 MG SC SOLR
Gross
$11,264
Q5111
$10,989
PEGFILGRASTIM-CBQV 6 MG/0.6ML SC SOSY
Gross
$10,989
| Code | Description | Gross | Cash | Min payer | Max payer | # insurers |
|---|---|---|---|---|---|---|
| J9043 | CABAZITAXEL 60 MG/6ML IV SOLN | $154,982 | $154,982 | — | — | 13 |
| J0223 | GIVOSIRAN SODIUM 189 MG/ML SC SOLN | $119,002 | $119,002 | — | — | 13 |
| J9347 | TREMELIMUMAB-ACTL 300 MG/15ML IV SOLN | $114,454 | $114,454 | — | — | 13 |
| J3357 | USTEKINUMAB 90 MG/ML SC SOSY | $80,569 | $80,569 | — | — | 13 |
| J0638 | CANAKINUMAB 150 MG/ML SC SOLN | $61,880 | $61,880 | — | — | 13 |
| J2350 | OCRELIZUMAB 300 MG/10ML IV SOLN | $57,156 | $57,156 | — | — | 13 |
| J3245 | TILDRAKIZUMAB-ASMN 100 MG/ML SC SOSY | $49,169 | $49,169 | — | — | 13 |
| J9298 | NIVOLUMAB-RELATLIMAB-RMBW 240-80 MG/20ML IV SOLN | $42,234 | $42,234 | — | — | 13 |
| J9345 | RETIFANLIMAB-DLWR 500 MG/20ML IV SOLN | $40,375 | $40,375 | — | — | 13 |
| J9306 | PERTUZUMAB 420 MG/14ML IV SOLN | $36,265 | $36,265 | — | — | 13 |
| J9042 | BRENTUXIMAB VEDOTIN 50 MG IV SOLR | $36,019 | $36,019 | — | — | 13 |
| J9277 | PEMBROLIZUMAB-BERAHYALUR-PMPH 395-4800 MG -UNT/2.4ML SC SOLN | $32,948 | $32,948 | — | — | 13 |
| J9272 | DOSTARLIMAB-GXLY 500 MG/10ML IV SOLN | $32,945 | $32,945 | — | — | 13 |
| J9022 | ATEZOLIZUMAB 1200 MG/20ML IV SOLN | $32,363 | $32,363 | — | — | 13 |
| J9119 | CEMIPLIMAB-RWLC 350 MG/7ML IV SOLN | $32,006 | $32,006 | — | — | 13 |
| J9144 | DARATUMUMAB-HYALURONIDASE-FIHJ 1800-30000 MG-UT/15ML SC SOLN | $30,586 | $30,586 | — | — | 13 |
| J2327 | RISANKIZUMAB-RZAA 600 MG/10ML IV SOLN | $29,402 | $29,402 | — | — | 13 |
| J3380 | VEDOLIZUMAB 300 MG IV SOLR | $26,608 | $26,608 | — | — | 13 |
| J9316 | PERTUZ-TRASTUZ-HYALURON-ZZXF 60-60-2000 MG-MG-U/ML SC SOLN | $25,519 | $25,519 | — | — | 13 |
| J9301 | OBINUTUZUMAB 1000 MG/40ML IV SOLN | $24,875 | $24,875 | — | — | 13 |
| J9228 | IPILIMUMAB 5 MG/ML IV SOLN (COMBINED) | $24,797 | $24,797 | — | — | 13 |
| J1930 | LANREOTIDE ACETATE 120 MG/0.5ML SC SOLN | $23,407 | $23,407 | — | — | 13 |
| J2323 | NATALIZUMAB 300 MG/15ML IV CONC | $23,372 | $23,372 | — | — | 13 |
| J3101 | TENECTEPLASE 25 MG IV KIT | $23,163 | $23,163 | — | — | 13 |
| J9223 | LURBINECTEDIN 4 MG IV SOLR | $22,584 | $22,584 | — | — | 13 |
| J0180 | AGALSIDASE BETA 35 MG IV SOLR | $21,222 | $21,222 | — | — | 13 |
| J1459 | PRIVIGEN 40 GM/400ML IV SOLN | $20,807 | $20,807 | — | — | 13 |
| J9308 | RAMUCIRUMAB 10 MG/ML IV SOLN (COMBINED) | $20,349 | $20,349 | — | — | 13 |
| 24341 | HC REPAIR TENDON/MUSCLE UPPER ARM/ELBOW EA TDN/MUSC | $19,460 | $19,460 | — | — | 13 |
| J9063 | MIRVETUXIMAB SORAVTANSINE-GYNX 100 MG/20ML IV SOLN | $18,302 | $18,302 | — | — | 13 |
| J1299 | ECULIZUMAB 300 MG/30ML IV SOLN | $17,170 | $17,170 | — | — | 13 |
| J9271 | PEMBROLIZUMAB 100 MG/4ML IV SOLN | $16,474 | $16,474 | — | — | 13 |
| 0313U | B* HC ONC PANCREATIC FLUID NGS ANALYS DNA&MRNA SEQ 74 | $16,472 | $16,472 | — | — | 13 |
| 21330 | HC OPEN TX NASAL FX COMP W/INT&/XTRNL SKELETAL FI | $15,876 | $15,876 | — | — | 13 |
| 21431 | HC CLOSED TX CRANIOFACIAL SEPARATION | $15,876 | $15,876 | — | — | 13 |
| J0517 | BENRALIZUMAB 30 MG/ML SC SOSY | $15,852 | $15,852 | — | — | 13 |
| Q5152 | ECULIZUMAB-AEEB 300 MG/30ML IV SOLN | $15,453 | $15,453 | — | — | 13 |
| J1569 | GAMMAGARD 30 GM/300ML IJ SOLN | $14,271 | $14,271 | — | — | 13 |
| J2506 | PEGFILGRASTIM 6 MG/0.6ML SC SOSY | $12,995 | $12,995 | — | — | 13 |
| J2356 | TEZEPELUMAB-EKKO 210 MG/1.91ML SC (COMBINED) | $12,644 | $12,644 | — | — | 13 |
| J2353 | OCTREOTIDE ACETATE 20 MG IM KIT | $12,637 | $12,637 | — | — | 13 |
| J9312 | RITUXIMAB 10 MG/ML IV CONC (COMBINED) | $12,365 | $12,365 | — | — | 13 |
| C1767 | DEVICE NEUROSTIMULATOR F15 | $12,150 | $12,150 | — | — | 11 |
| Q5151 | ECULIZUMAB-AAGH 300 MG/30ML IV SOLN | $12,019 | $12,019 | — | — | 13 |
| 81412 | B* HC ASHKENAZI JEWISH ASSOC DSRDRS GEN SEQ ANAL 9 GEN | $11,979 | $11,979 | — | — | 13 |
| J9173 | DURVALUMAB 500 MG/10ML IV SOLN | $11,935 | $11,935 | — | — | 13 |
| J9309 | POLATUZUMAB VEDOTIN-PIIQ 30 MG IV SOLR | $11,461 | $11,461 | — | — | 13 |
| J0739 | CABOTEGRAVIR ER 600 MG/3ML IM SUER | $11,410 | $11,410 | — | — | 13 |
| J0896 | LUSPATERCEPT-AAMT 25 MG SC SOLR | $11,264 | $11,264 | — | — | 13 |
| Q5111 | PEGFILGRASTIM-CBQV 6 MG/0.6ML SC SOSY | $10,989 | $10,989 | — | — | 13 |
Showing top 50 of 19,188 priced procedures, sorted by gross charge.
Data straight from this hospital's own published price file (45 CFR § 180). The grade scores how completely the file contains the six required data elements. It is a check of the file — not a CMS compliance ruling, and not a measure of quality of care.